OverviewSuggest Edit

    Yiviva is a biotechnology company developing therapeutics to treat cancer, chronic, and inflammatory diseases. It offers STAR (Signal Transduction, Action and Response) discovery platform screening high potential herbs from traditional medicine, gaining insights into how different herbs act on key pathways and affect biological responses, etc. The company also provides a candidate cancer drug YIV-906.

    Latest Updates

    Employees (est.) (Oct 2021)5
    Cybersecurity ratingCMore
    Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
    Banner background

    Key People/Management at Yiviva

    Huey Liu

    Huey Liu

    Co-Founder and Chief Scientific Officer
    Henry Bronson

    Henry Bronson

    Co-Founder and Professor of Pharmacology, Yale University
    William Cheng

    William Cheng

    Director, Data Engineering
    Peikwen Cheng

    Peikwen Cheng

    Co-founder and CEO
    Show more

    Yiviva Financials and Metrics

    Summary Metrics

    Founding Date


    Yiviva Cybersecurity Score

    Cybersecurity ratingPremium dataset



    SecurityScorecard logo

    Yiviva Online and Social Media Presence

    Embed Graph

    Yiviva News and Updates

    Yiviva Wins 2 Top Awards at SAPA Investment Forum and Road Show for Innovative Systems Biology Approach to Treat Cancer

    NEW YORK and SHANGHAI, China, July 30, 2021 (GLOBE NEWSWIRE) -- Yiviva, a clinical-stage biotechnology company that uses a systems-biology approach to treat aging-associated diseases, won two top awards at the 4th annual Sino-American Pharmaceutical Professionals Association (SAPA) Investment Foru…

    Yiviva Frequently Asked Questions

    • When was Yiviva founded?

      Yiviva was founded in 2014.

    • Who are Yiviva key executives?

      Yiviva's key executives are Huey Liu, Henry Bronson and William Cheng.

    • How many employees does Yiviva have?

      Yiviva has 5 employees.

    • Who are Yiviva competitors?

      Competitors of Yiviva include Janssen Pharmaceuticals, Resonant Therapeutics and ConfometRx.